Wang Bin, Dyer Wayne B, Zaunders John J, Mikhail Meriet, Sullivan John S, Williams Lisa, Haddad Da'ed N, Harris Graeme, Holt John A G, Cooper David A, Miranda-Saksena Monica, Boadle Ross, Kelleher Anthony D, Saksena Nitin K
Retroviral Genetics Laboratory, Centre for Virus Research, Westmead Millennium Institute, Westmead Hospital, University of Sydney, Westmead, New South Wales 2145, Australia.
Virology. 2002 Dec 20;304(2):246-64. doi: 10.1006/viro.2002.1706.
We recently demonstrated that a unique HIV-1-infected nonprogressor was infected with a nonevolving replication-incompetent HIV-1 strain, showing a total absence of viral evolution in vivo. Potent immune responses against HIV-1 were observed in his PBMC, despite an apparent lack of viral replication for at least 8 years. His PBMC resisted superinfection with CCR5, CXCR4, and dual-tropic HIV-1 strains, although highly purified CD4+ T cells supported infection, but without any visible cytopathic effect. Potent noncytolytic CD8+ T cell antiviral activity was shown to protect his PBMC from productive infection. This activity was not mediated by several known chemokines or IFN-gamma, which were produced at high levels after PHA activation of his CD8+ T cells, indicating the action of other CAF-like CD8 factors. This antiviral activity was a memory response, induced by HIV-specific stimulation to similar levels observed by PHA stimulation, but absent in ex vivo resting T cells. Immunological mechanisms associated with this antiviral suppressive activity included vigorous Gag-specific helper T cell proliferative responses and high-level IFN-gamma release by both CD4 and CD8 T cells. These responses were broadly directed against multiple Gag epitopes, both previously reported and some novel epitopes. Strong HIV-specific helper T cell function was also associated with strong neutralizing antibodies. Understanding how to induce these protective immune responses in other individuals could provide a major step forward in the design of effective immunotherapies or vaccines against HIV infection.
我们最近证明,一名独特的HIV-1感染非进展者感染了一种不进化且无复制能力的HIV-1毒株,在体内完全没有病毒进化。尽管至少8年明显缺乏病毒复制,但在他的外周血单核细胞(PBMC)中观察到了针对HIV-1的强效免疫反应。他的PBMC抵抗CCR5、CXCR4和双嗜性HIV-1毒株的超感染,尽管高度纯化的CD4+T细胞支持感染,但没有任何可见的细胞病变效应。强效的非细胞溶解CD8+T细胞抗病毒活性被证明可保护他的PBMC免受生产性感染。这种活性不是由几种已知的趋化因子或干扰素-γ介导的,这些因子在他的CD8+T细胞经PHA激活后大量产生,表明存在其他类似CAF的CD8因子的作用。这种抗病毒活性是一种记忆反应,由HIV特异性刺激诱导至PHA刺激所观察到的类似水平,但在体外静息T细胞中不存在。与这种抗病毒抑制活性相关的免疫机制包括强烈的Gag特异性辅助性T细胞增殖反应以及CD4和CD8 T细胞高水平释放干扰素-γ。这些反应广泛针对多个Gag表位,包括先前报道的和一些新表位。强大的HIV特异性辅助性T细胞功能也与强大的中和抗体相关。了解如何在其他个体中诱导这些保护性免疫反应可能是设计针对HIV感染的有效免疫疗法或疫苗的重要一步。